• Research Topics

  ALS: Daiichi Sankyo Seeks Approval to Market Radicava in Brazil

  Posted by ALS News Today Moderator on September 26, 2019 at 10:03 am

  

  Daiichi Sankyo is seeking approval to market the ALS treatment Radicava in Brazil, after reaching a licensing agreement with Mitsubishi Tanabe Pharma. Read more about it here. Click here to read more.

  What do you think of this news?

  replied 4 years, 7 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply